Urethral disorder
MONDO:0004184A disease involving the urethra.
Also known as: disease of urethra, disease or disorder of urethra, disorder of urethra, urethra disease, urethra disease or disorder, urethra disorder
70 clinical trials for this condition and its sub-types, 1 tagged with Urethral disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Urethral disorder
-
Urethra neoplasm 3 trials · 31 incl. sub-types
3 sub-types
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Benign urethral neoplasm 0 trials Sub-types →
- Urethral villous adenoma 0 trials
-
Urethral obstruction 3 trials · 26 incl. sub-types
2 sub-types
- Urethral stricture 23 trials Sub-types →
- Urethral obstruction sequence 0 trials
-
Urethritis 5 trials · 6 incl. sub-types
2 sub-types
- Ureaplasma urethritis 1 trial
- Gonococcal urethritis 0 trials
-
Urethral syndrome 4 trials
-
Fibroepithelial polyp of urethra 0 trials
-
Prolapse of urethra 0 trials
-
Urethral calculus 0 trials
-
Urethral false passage 0 trials
-
Urethral gland abscess 0 trials
Most studied deeper sub-types
-
Experimental combo for tough cancers shows early promise, but trial halted
Disease control Stopped earlyThis early-phase study tested a combination of two drugs—atezolizumab (an immunotherapy) and epacadostat (an oral drug that helps the immune system attack cancer)—in 29 patients with advanced lung or bladder cancer that had already been treated with chemotherapy. The main goal wa…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control Stopped earlyThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial included 348 participants but was te…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC